Skip to content

Monday, September 15, 2025

Latest:

Healthy Habits: Dr. Jorge Miranda focuses on moderation
Severe eating disorders are on the rise among adolescents: How supporting their parents may be the most critical first step
Ask Me About My Research with Dr. Felipe Andrés Piedra
How to exercise after 40
Refractive eye surgery: Understanding your options to be free of glasses or contacts

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

TopBP1

5D4 disrupts several molecular pathways, including MYC, that lead to cancer growth

October 26, 2023 5D4, Breast Cancer, cancer inhibitor, MYC, ovarian cancer, PARP inhibitor, Research, TopBP1

The findings strongly support the potential use of TopBP1 inhibitors as a targeted cancer therapy.

From the Labs: Image of the Month

From the Labs: a closer look at Barrett's esophagus

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951